Thanks to Fallond for the generous donation to my ‘tip jar’ today. In addition to his main site (which I know you all bookmarked back in June 2004 when I first mentioned it.) He also has a blog now. There’s plenty of good info on both sites.
As for the market… Is it September yet??? I had another non-trading day yesterday due to the lethargic action in the indices. I’m not expecting much today either. I certainly could be wrong, but as always time will tell.
If you’re trying to subscribe to my new links feed(s) you’re probably getting an XML error right now. I’ve reported the problem and hopefully it will be fixed very soon. The latest links are displayed on the site though.
Potential swing trades:
Longs – None
Shorts – None
Potential day trades:
(From Briefing.com)
Gapping Down
Gapping down on disappointing earnings/guidance: LTXX -12%, PETC -10% (also multiple downgrades), CMOS -8.4% (also Adams Harkness downgrade), AGIL -5.4% (also Needham downgrade)… Other News: DOVP -15% (suspends ocinaplon trial), DRL -7.1% (receives subpoena from US Atty; cut to Source of Funds at ThinkEquity), ELN -5% (additional highly suspect Tysabri deaths obtained by Morgan Stanley; BIIB -2.1%), RNVS -4.7% (clinical data), ISRG -3.5% (started with an Underperform at Jefferies; tgt $65), STX -3% (Morgan Stanley downgrade), PIXR -3% (faces informal SEC probe – WSJ).
Gapping UpOVTI +15% (reports JulQ; guides OctQ revs above consensus; short squeeze), LWAY +21% (to begin distribution to limited test market), ZIGO +10% (reports JunQ), LC +25% (to merge with Raycom Media), QUIN +16%, SBTV +8%, AGIX +6.4% (may be a buyout – BusinessWeek), OPTC +5% (extends recent momentum), BCON +3% (extends recent momentum)… Under $3: DFIB +28% (receives approval from Japanese govt to market biphasic version AEDs in Japan), CNR +17% (announces positive well apraisal), MCEL +4% (extends recent momentum).
Intraday Updates:
- 00:00
Disclaimer & How I use this list



Thanks for the plug Mike. I will be interested to see how you get on using Trade-Ideas. I like their format but haven’t figured how best to use it myself.
Best wishes,
Declan